Literature DB >> 36069545

G1/S Cell Cycle Induction by Epstein-Barr Virus BORF2 Is Mediated by P53 and APOBEC3B.

Jaime Yockteng-Melgar1,2, Kathy Shire1, Adam Z Cheng3, Natasha Malik-Soni1, Reuben S Harris3,4,5, Lori Frappier1.   

Abstract

Herpesvirus lytic infection causes cells to arrest at the G1/S phase of the cell cycle by poorly defined mechanisms. In a prior study using fluorescent ubiquitination-based cell cycle indicator (FUCCI) cells that express fluorescently tagged proteins marking different stages of the cell cycle, we showed that the Epstein-Barr virus (EBV) protein BORF2 induces the accumulation of G1/S cells, and that BORF2 affects p53 levels without affecting the p53 target protein p21. We also found that BORF2 specifically interacted with APOBEC3B (A3B) and forms perinuclear bodies with A3B that prevent A3B from mutating replicating EBV genomes. We now show that BORF2 also interacts with p53 and that A3B interferes with the BORF2-p53 interaction, although A3B and p53 engage distinct surfaces on BORF2. Cell cycle analysis showed that G1/S induction by BORF2 is abrogated when either p53 or A3B is silenced or when an A3B-binding mutant of BORF2 is used. Furthermore, silencing A3B in EBV lytic infection increased cell proliferation, supporting a role for A3B in G1/S arrest. These data suggest that the p53 induced by BORF2 is inactive when it binds BORF2, but is released and induces G1/S arrest when A3B is present and sequesters BORF2 in perinuclear bodies. Interestingly, this mechanism is conserved in the BORF2 homologue in HSV-1, which also re-localizes A3B, induces and binds p53, and induces G1/S dependent on A3B and p53. In summary, we have identified a new mechanism by which G1/S arrest can be induced in herpesvirus lytic infection. IMPORTANCE In lytic infection, herpesviruses cause cells to arrest at the G1/S phase of the cell cycle in order to provide an optimal environment for viral replication; however, the mechanisms involved are not well understood. We have shown that the Epstein-Barr virus BORF2 protein and its homologue in herpes simplex virus 1 both induce G1/S, and do this by similar mechanisms which involve binding p53 and APOBEC3B and induction of p53. Our study identifies a new mechanism by which G1/S arrest can be induced in herpesvirus lytic infection and a new role of APOBEC3B in herpesvirus lytic infection.

Entities:  

Keywords:  APOBEC3B; BORF2; Epstein-Barr virus; G1/S; ICP6; UL39; cell cycle; herpes simplex virus; p53

Mesh:

Substances:

Year:  2022        PMID: 36069545      PMCID: PMC9517719          DOI: 10.1128/jvi.00660-22

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   6.549


  60 in total

1.  The ribonucleotide reductase R1 subunits of herpes simplex virus 1 and 2 protect cells against poly(I · C)-induced apoptosis.

Authors:  Florent Dufour; Luc Bertrand; Angela Pearson; Nathalie Grandvaux; Yves Langelier
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

2.  The ribonucleotide reductase R1 subunits of herpes simplex virus types 1 and 2 protect cells against TNFα- and FasL-induced apoptosis by interacting with caspase-8.

Authors:  Florent Dufour; A Marie-Josée Sasseville; Stéphane Chabaud; Bernard Massie; Richard M Siegel; Yves Langelier
Journal:  Apoptosis       Date:  2011-03       Impact factor: 4.677

3.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

4.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

5.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

6.  A Screen for Epstein-Barr Virus Proteins That Inhibit the DNA Damage Response Reveals a Novel Histone Binding Protein.

Authors:  Ting-Hin Ho; Justine Sitz; Qingtang Shen; Ariane Leblanc-Lacroix; Eric I Campos; Ivan Borozan; Edyta Marcon; Jack Greenblatt; Amelie Fradet-Turcotte; Dong-Yan Jin; Lori Frappier
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

Review 7.  Epstein-Barr virus latent genes.

Authors:  Myung-Soo Kang; Elliott Kieff
Journal:  Exp Mol Med       Date:  2015-01-23       Impact factor: 8.718

8.  PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry.

Authors:  Martin Eifler; Ralf Uecker; Henry Weisbach; Boris Bogdanow; Ellen Richter; Lydia König; Barbara Vetter; Tihana Lenac-Rovis; Stipan Jonjic; Heidemarie Neitzel; Christian Hagemeier; Lüder Wiebusch
Journal:  PLoS Pathog       Date:  2014-11-13       Impact factor: 6.823

Review 9.  Emerging Mechanisms of G1/S Cell Cycle Control by Human and Mouse Cytomegaloviruses.

Authors:  Boris Bogdanow; Quang Vinh Phan; Lüder Wiebusch
Journal:  mBio       Date:  2021-12-14       Impact factor: 7.867

10.  Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies.

Authors:  Jayme Salsman; Nicole Zimmerman; Tricia Chen; Megan Domagala; Lori Frappier
Journal:  PLoS Pathog       Date:  2008-07-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.